Ocugen, Inc. (OCGN)
1.02
+0.02
(+2.00%)
USD |
NASDAQ |
Oct 02, 16:00
1.03
+0.01
(+0.98%)
After-Hours: 04:03
Ocugen Net Income (Quarterly) : -24.88M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -24.88M |
| March 31, 2026 | -19.18M |
| December 31, 2025 | -17.71M |
| September 30, 2025 | -20.05M |
| June 30, 2025 | -14.74M |
| March 31, 2025 | -15.35M |
| December 31, 2024 | -13.88M |
| September 30, 2024 | -12.97M |
| June 30, 2024 | -15.28M |
| March 31, 2024 | -11.92M |
| December 31, 2023 | -10.97M |
| September 30, 2023 | -11.72M |
| June 30, 2023 | -23.06M |
| March 31, 2023 | -17.33M |
| December 31, 2022 | -22.39M |
| September 30, 2022 | -21.92M |
| June 30, 2022 | -19.47M |
| March 31, 2022 | -18.02M |
| December 31, 2021 | -14.58M |
| September 30, 2021 | -10.76M |
| June 30, 2021 | -25.95M |
| March 31, 2021 | -7.077M |
| December 31, 2020 | -3.790M |
| September 30, 2020 | -10.47M |
| June 30, 2020 | -3.614M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.944M |
| December 31, 2019 | 12.38M |
| September 30, 2019 | -22.77M |
| June 30, 2019 | -3.539M |
| March 31, 2019 | -6.313M |
| December 31, 2018 | -5.957M |
| September 30, 2018 | -1.933M |
| June 30, 2018 | -3.777M |
| March 31, 2018 | -14.83M |
| December 31, 2017 | -6.796M |
| September 30, 2017 | -5.995M |
| June 30, 2017 | -6.542M |
| March 31, 2017 | -7.081M |
| December 31, 2016 | 9.063M |
| September 30, 2016 | -9.315M |
| June 30, 2016 | -8.038M |
| March 31, 2016 | -7.918M |
| December 31, 2015 | -8.349M |
| September 30, 2015 | -8.078M |
| June 30, 2015 | -7.633M |
| March 31, 2015 | -7.964M |
| December 31, 2014 | 9.622M |
| September 30, 2014 | -11.97M |
| June 30, 2014 | -11.82M |
| March 31, 2014 | -3.437M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Gilead Sciences, Inc. | -10.50B |
| MannKind Corp. | -19.03M |
| Nektar Therapeutics | -40.62M |
| Vertex Pharmaceuticals, Inc. | 1.100B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.488M |
| Total Expenses (Quarterly) | 26.36M |
| EPS Diluted (Quarterly) | -0.0734 |
| Enterprise Value | 333.76M |
| Gross Profit Margin (Quarterly) | 60.62% |
| Profit Margin (Quarterly) | -1.67K% |
| Earnings Yield | -24.97% |
| Normalized Earnings Yield | -24.10 |